Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

Systematic review: an evaluation of major commercial weight loss programs in the United States.

Tsai AG, Wadden TA.

Ann Intern Med. 2005 Jan 4;142(1):56-66. Review.

PMID:
15630109
2.

Summaries for patients. Evaluation of the major commercial weight loss programs.

[No authors listed]

Ann Intern Med. 2005 Jan 4;142(1):I42. No abstract available.

PMID:
15630103
3.

Industry-sponsored weight loss programs: description, cost, and effectiveness.

Witherspoon B, Rosenzweig M.

J Am Acad Nurse Pract. 2004 May;16(5):198-205.

PMID:
15193022
4.

Weight loss on the web: A pilot study comparing a structured behavioral intervention to a commercial program.

Gold BC, Burke S, Pintauro S, Buzzell P, Harvey-Berino J.

Obesity (Silver Spring). 2007 Jan;15(1):155-64.

5.

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study.

Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, Phinney SD, Miller-Kovach K, Xavier Pi-Sunyer F.

Am J Med. 2000 Sep;109(4):282-7.

PMID:
10996578
6.

The cost of losing: an analysis of commercial weight-loss programs in a metropolitan area.

Spielman AB, Kanders B, Kienholz M, Blackburn GL.

J Am Coll Nutr. 1992 Feb;11(1):36-41. Review.

PMID:
1541793
7.

Meta-analysis: the effect of dietary counseling for weight loss.

Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM.

Ann Intern Med. 2007 Jul 3;147(1):41-50. Review.

PMID:
17606960
8.

A review of weight loss programs delivered via the Internet.

Weinstein PK.

J Cardiovasc Nurs. 2006 Jul-Aug;21(4):251-8; quiz 259-60. Review. Erratum in: J Cardiovasc Nurs. 2007 Mar-Apr;22(2):137.

PMID:
16823276
9.

A randomized controlled trial of a commercial internet weight loss program.

Womble LG, Wadden TA, McGuckin BG, Sargent SL, Rothman RA, Krauthamer-Ewing ES.

Obes Res. 2004 Jun;12(6):1011-8.

10.

Thirty-month evaluation of a popular very-low-calorie diet program.

Flynn TJ, Walsh MF.

Arch Fam Med. 1993 Oct;2(10):1042-8.

PMID:
8111485
11.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

12.

Efficacy of commercial weight-loss programs: an updated systematic review.

Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, Lee CJ, Bleich SN, Clark JM.

Ann Intern Med. 2015 Apr 7;162(7):501-12. doi: 10.7326/M14-2238. Review. Erratum in: Ann Intern Med. 2015 May 19;162(10):739-40.

13.

Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors.

Djuric Z, DiLaura NM, Jenkins I, Darga L, Jen CK, Mood D, Bradley E, Hryniuk WM.

Obes Res. 2002 Jul;10(7):657-65.

14.

Effectiveness of the online weight reduction program KiloCoachâ„¢ and comparison with other evaluated commercial direct intervention and online programs.

Longin R, Grasse M, Aspalter R, Waldherr K.

Obes Facts. 2012;5(3):372-83. doi: 10.1159/000339726. Epub 2012 Jun 14.

15.

Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities.

Hession M, Rolland C, Kulkarni U, Wise A, Broom J.

Obes Rev. 2009 Jan;10(1):36-50. doi: 10.1111/j.1467-789X.2008.00518.x. Epub 2008 Aug 11. Review.

PMID:
18700873
16.

Minimal in-person support as an adjunct to internet obesity treatment.

Micco N, Gold B, Buzzell P, Leonard H, Pintauro S, Harvey-Berino J.

Ann Behav Med. 2007 Feb;33(1):49-56.

PMID:
17291170
17.

High attrition rates in commercial weight reduction programs.

Volkmar FR, Stunkard AJ, Woolston J, Bailey RA.

Arch Intern Med. 1981 Mar;141(4):426-8.

PMID:
7212881
18.

Web-based weight management programs in an integrated health care setting: a randomized, controlled trial.

Rothert K, Strecher VJ, Doyle LA, Caplan WM, Joyce JS, Jimison HB, Karm LM, Mims AD, Roth MA.

Obesity (Silver Spring). 2006 Feb;14(2):266-72.

19.

Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A.

Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. Review.

20.

Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.

Lacey LA, Wolf A, O'shea D, Erny S, Ruof J.

Int J Obes (Lond). 2005 Aug;29(8):975-82.

PMID:
15852050

Supplemental Content

Support Center